These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 12088204

  • 1. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.
    Bossolasco P, Ricci C, Farina G, Soligo D, Pedretti D, Scanni A, Deliliers GL.
    Cancer Detect Prev; 2002; 26(1):60-3. PubMed ID: 12088204
    [Abstract] [Full Text] [Related]

  • 2. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
    Corradini P, Voena C, Astolfi M, Delloro S, Pilotti S, Arrigoni G, Bregni M, Pileri A, Gianni AM.
    Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
    [Abstract] [Full Text] [Related]

  • 3. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A, Kulik J, Kober P, Brewczyńska E, Pieńkowski T, Siedlecki JA.
    Acta Biochim Pol; 2004 Dec; 51(3):747-55. PubMed ID: 15448736
    [Abstract] [Full Text] [Related]

  • 4. Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products.
    Silva AL, Tomé MJ, Correia AE, Passos-Coelho JL.
    Ann Oncol; 2002 Mar; 13(3):422-9. PubMed ID: 11996474
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.
    Ooka M, Tamaki Y, Sakita I, Fujiwara Y, Yamamoto H, Miyake Y, Sekimoto M, Ohue M, Sugita Y, Miyoshi Y, Ikeda N, Noguchi S, Monden M.
    Breast Cancer Res Treat; 2001 May; 67(2):169-75. PubMed ID: 11519865
    [Abstract] [Full Text] [Related]

  • 6. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T, Gatzemeier W, Scharnberg P, Jürgens B, Wörmann B, Becker H, Rauschecker HF, Hiddemann W, Wulf GG.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 May; 115(Suppl I):277-80. PubMed ID: 14518259
    [Abstract] [Full Text] [Related]

  • 7. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
    Fortunato L, Mascaro A, Baldi A, Farina M, Cortese G, Ventrone MA, Amini M, Vitelli C.
    Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
    [Abstract] [Full Text] [Related]

  • 8. Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients.
    Cerveira N, Torres L, Rocha P, Bizarro S, Pereira D, Abreu J, Henrique R, Teixeira MR, Castedo S.
    Int J Cancer; 2004 Feb 10; 108(4):592-5. PubMed ID: 14696125
    [Abstract] [Full Text] [Related]

  • 9. Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers--a molecular study of 59 patients.
    Ghaffari SR, Sabokbar T, Tahmasebi S, Dastan J, Shorakae S, Moradi A, Tirgari F, Mohagheghi MA, Mosavi-Jarrahi A.
    Asian Pac J Cancer Prev; 2006 Feb 10; 7(3):396-8. PubMed ID: 17059329
    [Abstract] [Full Text] [Related]

  • 10. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
    Wulf GG, Jürgens B, Liersch T, Gatzemeier W, Rauschecker H, Buske C, Hüfner M, Hiddemann W, Wörmann B.
    J Cancer Res Clin Oncol; 1997 Feb 10; 123(9):514-21. PubMed ID: 9341902
    [Abstract] [Full Text] [Related]

  • 11. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K, Oltedal S, Farmen RK, Shammas FV, Heikkilä R, Kvaløy JT, Gilje B, Smaaland R, Nordgård O.
    Clin Breast Cancer; 2010 Oct 01; 10(5):378-84. PubMed ID: 20920982
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpé S, Van Marck E, Vermeulen PB, Dirix LY.
    Clin Breast Cancer; 2006 Jun 01; 7(2):146-52. PubMed ID: 16800974
    [Abstract] [Full Text] [Related]

  • 13. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
    Skondra M, Gkioka E, Kostakis ID, Pissimissis N, Lembessis P, Pectasides D, Koutsilieris M.
    Anticancer Res; 2014 Nov 01; 34(11):6691-9. PubMed ID: 25368276
    [Abstract] [Full Text] [Related]

  • 14. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
    Tjensvoll K, Gilje B, Oltedal S, Shammas VF, Kvaløy JT, Heikkilä R, Nordgård O.
    Breast Cancer Res Treat; 2009 Jul 01; 116(2):329-38. PubMed ID: 18846421
    [Abstract] [Full Text] [Related]

  • 15. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer.
    Fleming TP, Watson MA.
    Ann N Y Acad Sci; 2000 Jul 01; 923():78-89. PubMed ID: 11193781
    [Abstract] [Full Text] [Related]

  • 16. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction.
    Aihara T, Fujiwara Y, Ooka M, Sakita I, Tamaki Y, Monden M.
    Breast Cancer Res Treat; 1999 Nov 01; 58(2):137-40. PubMed ID: 10674878
    [Abstract] [Full Text] [Related]

  • 17. Mammaglobin RT-qPCR for breast cancer metastasis detection in sentinel lymph nodes.
    Span PN, Van Laarhoven HW, Sweep FC.
    Cancer Sci; 2010 Nov 01; 101(11):2501; author reply 2502. PubMed ID: 20950374
    [Abstract] [Full Text] [Related]

  • 18. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y, Zou TN, Wu ZP, Zhou YC, Gu YL, Liu X, Jin CG, Wang XC.
    Int J Biol Markers; 2010 Nov 01; 25(2):59-68. PubMed ID: 20586026
    [Abstract] [Full Text] [Related]

  • 19. Mammaglobin as a marker for the detection of tumor cells in the peripheral blood of breast cancer patients.
    Zach O, Kasparu H, Wagner H, Krieger O, Lutz D.
    Ann N Y Acad Sci; 2000 Nov 01; 923():343-5. PubMed ID: 11193775
    [No Abstract] [Full Text] [Related]

  • 20. Detection of mammaglobin mRNA in the plasma of breast cancer patients.
    Gal S, Fidler C, Lo YM, Chin K, Moore J, Harris AL, Wainscoat JS.
    Ann N Y Acad Sci; 2001 Sep 01; 945():192-4. PubMed ID: 11708478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.